ENTERA BIO LTD. Adjusted Weighted Average Shares
ENTERA BIO LTD. (ENTX) reported Adjusted Weighted Average Shares of 24.72 million shares for the 3-month period ending 2021-06-30, per its 6-K filed 2021-08-16.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:AdjustedWeightedAverageShares · last filed 2021-08-16
- ENTERA BIO LTD. adjusted weighted average shares for the quarter ending 2021-06-30 was 24.72M shares, a 35.55% increase year-over-year.
- ENTERA BIO LTD. adjusted weighted average shares for the quarter ending 2020-06-30 was 18.23M shares, a 55.28% increase year-over-year.
- ENTERA BIO LTD. adjusted weighted average shares for the quarter ending 2019-06-30 was 11.74M shares.
| Period end | Adjusted Weighted Average Shares 3 month | Adjusted Weighted Average Shares 6 month | Adjusted Weighted Average Shares 12 month |
|---|---|---|---|
| 2021-06-30 | 24.72M shares 6-K · filed 2021-08-16 | 23.38M shares 6-K · filed 2021-08-16 | |
| 2020-12-31 | 18.56M shares 20-F · filed 2021-03-18 | ||
| 2020-06-30 | 18.23M shares 6-K · filed 2021-08-16 | 18.14M shares 6-K · filed 2021-08-16 | |
| 2019-12-31 | 12.15M shares 20-F · filed 2021-03-18 | ||
| 2019-06-30 | 11.74M shares 6-K · filed 2020-08-20 | 11.60M shares 6-K · filed 2020-08-20 | |
| 2018-12-31 | 7.98M shares 20-F · filed 2021-03-18 | ||
| 2017-12-31 | 4.49M shares 20-F · filed 2020-03-26 | ||
| 2016-12-31 | 6.76M shares 20-F · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |